[HTML][HTML] Pneumocystis jirovecii pneumonia in developing countries
YDA Rodríguez, G Wissmann, AL Müller… - Parasite: journal de la …, 2011 - ncbi.nlm.nih.gov
Pneumocystis pneumonia (PcP) is a serious fungal infection among immunocompromised
patients. In developed countries, the epidemiology and clinical spectrum of PcP have been …
patients. In developed countries, the epidemiology and clinical spectrum of PcP have been …
Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings
Strategies to reduce early morbidity and mortality in adults... : Current Opinion in HIV and AIDS
Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in …
Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in …
Toxoplasmosis in HIV/AIDS patients: a living legacy
V Nissapatorn - Microbes, Viruses and Parasites in AIDS …, 2009 - books.google.com
The coccidian Toxoplasma gondii (T. gondii) is a ubiquitous, intracellular, protozoan
parasite that causes toxoplasmosis, a cosmopolitan zoonotic disease. Toxoplasma …
parasite that causes toxoplasmosis, a cosmopolitan zoonotic disease. Toxoplasma …
[HTML][HTML] Survival rate and mortality risk factors among TB–HIV co-infected patients at an HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study
Background Myanmar is listed as one of the countries with the highest burden of
tuberculosis and HIV infections (TB–HIV) in the world. However, the survival rate and risk …
tuberculosis and HIV infections (TB–HIV) in the world. However, the survival rate and risk …
[PDF][PDF] Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis
OBJECTIVE: To determine whether cotrimoxazole reduces mortality in adults receiving
antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection in low-and …
antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection in low-and …
[HTML][HTML] Prevalence and incidence rate of tuberculosis among HIV-infected patients enrolled in HIV care, treatment, and support program in mainland Tanzania
Background Despite improvements in access to antiretroviral therapy (ART), mortality in
people living with human immunodeficiency virus (PLHIV) is still high and primarily …
people living with human immunodeficiency virus (PLHIV) is still high and primarily …
HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes
Objective To determine the rates of death and infection from HIV in India. Design Nationally
representative survey of deaths. Setting 1.1 million homes in India. Population 123 000 …
representative survey of deaths. Setting 1.1 million homes in India. Population 123 000 …
[HTML][HTML] Outcomes and factors associated with survival of patients with HIV/AIDS initiating antiretroviral treatment in Liangshan Prefecture, southwest of China: A …
G Zhang, Y Gong, Q Wang, L Deng, S Zhang, Q Liao… - Medicine, 2016 - journals.lww.com
Human immunodeficiency virus (HIV)–positive cases have been reported among people
who injected drugs in Liangshan Prefecture in southwest of China since 1995 and …
who injected drugs in Liangshan Prefecture in southwest of China since 1995 and …
[PDF][PDF] HIV Treatment Adherence-A Shared Burden for Patients, Health-Care Providers, and Other Stakeholders.
Successful HIV treatment is contingent on sustained high levels of treatment adherence.
Several barriers to optimal adherence have been documented. In this article, we first review …
Several barriers to optimal adherence have been documented. In this article, we first review …
Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam
Background: There is a lack of knowledge on mortality and causes of death among human
immunodeficiency virus (HIV)-infected patients after initiation of antiretroviral therapy (ART) …
immunodeficiency virus (HIV)-infected patients after initiation of antiretroviral therapy (ART) …